期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

EGFR VEGFR-3 PDGFRa在三阴乳腺癌中的表达及其临床意义 被引量：5

在线阅读 下载PDF
导出
摘要 近年来，寻找三阴乳腺癌（triple negative breast cancer，TNBC）新的治疗靶点成为国际上乳腺癌研究的新热点，表皮生长因子受体（EGFR）、血管内皮生长因子受体3（VEGFR-3）、血小板源性生长因子受体a（PDGFRa）等是被广泛研究的具有受体酪氨酸激酶（PTK）活性的受体。
作者 宋新峰 路喜安
机构地区 德州学院医学系 山西医科大学第一医院病理科
出处 《中国药物与临床》 CAS 2012年第12期1560-1562,共3页 Chinese Remedies & Clinics
关键词 三阴乳腺癌 VEGFR-3 PDGFRA 临床意义 血小板源性生长因子受体 表皮生长因子受体 血管内皮生长因子受体 受体酪氨酸激酶
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献9

  • 1Dancey J, Sausville EA. Issues and progress with protein kinaseinhibitors for cancer treatment. Nat Rev Drug Discover, 2003,2 ;293-313.
  • 2Nalwoga H, Ames JB,Wabinga H,et al. Expression of EGFR andc-kit is associated with the basal-like phenotype in breast carci-nomas of African women. APMIS,2008,116(6) :515-525.
  • 3Vranic S,Frkovic-Grazio S,Lamovec J,et al. Adenoid cystic car-cinomas of the breast have low Topo H a expression but fre-quently overexpress EGFR protein without EGFR gene amplifi-cation. HumanPathol,2010,41(11) : 1617-1623.
  • 4Cleator S, Heller W, Coombes RC. Triple-negative breast cancer :therapeutic options. Lancet Oncol ,2007,8(3) :235-244.
  • 5刘万军,宋岩.EGFR在三阴乳腺癌中的过表达与扩增情况分析[J].中国当代医药,2012,19(3):10-11. 被引量：3
  • 6Valtola R,Salven P,Heikkila P,et al. VEGFR-3 and its ligandVEGF-C are associated with angiogenesis in breast cancer. AmPathol, 1999,154(5) :1381-1390.
  • 7刘得水,张晓杰,陈刚,卢长方,董海影.血小板源性生长因子受体-α及其配体PDGF-A在人乳腺癌中表达的意义[J].细胞与分子免疫学杂志,2011,27(3):313-314. 被引量：4
  • 8Carvalho L,Milanezi E,Matin A,et al. Over exprssion of platele-derived growth factor receptor a in breast cancer is assosiatedwith tumor progression. Breast Cancer Res,2005,7:788-795.
  • 9Jechlinger M,Sommer A,Moriggl R,et al. Autocrine PDGFR sig-naling promotes mammary cancer metastasis. J Clin Invest, 2006,116(6):1561-1570.

二级参考文献29

  • 1Betsholtz C, Karlsson L. Developmental roles of platelet-derived growth factors[J]. Bioessays. 2001, 23(6) : 494 -507.
  • 2Apte SM, Bucana CD, Killion JJ, et al. Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelialovarian canner and ovarian carcinoma cell line[ J]. Gynecol Oncol, 2004, 93 ( 1 ) : 78 - 86.
  • 3Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma[ J]. Cytokine Growth Factor Rev, 2004, 15(4) : 275 -286.
  • 4Kim R, Emi M, Arihiro K, et al. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma[ J]. Cancer, 2005, 103 (9) : 1800 - 1809.
  • 5Oseini AM, Roberts LR. PDGFRalpha : a new therapeutic target in the treatment of hepatocellular carcinoma? [ J ]. Expert Opin Ther Targets, 2009, 13(4) : 443 -454.
  • 6Miguita L, Martinez EF, de Araújo NS, de Araújo VC. FGF-2, TGF- beta-l, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study[J]. J Appl Oral Sci, 2010, 18(1) : 83 -91.
  • 7Petit A, Castillo M, Gaspa A, et al. Expression and mutational analyses of KIT and PDGFR-alpha in sarcomatoid renal cell carcinoma [J]. Histopathology, 2009, 55(2): 230-232.
  • 8Hunter SB, Brat DJ, Olson JJ, et al. Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and antitumar therapy [ J ]. Int J Oncol, 2003,23 (4) : 857 - 869.
  • 9De Jong JS, Van Diest PJ, Der Valk PV, et al. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: an inventory in search of autocrine and paracrine loops[J]. J Pathol, 1998, 184(1) : 44-52.
  • 10Bryan BB,Schni/I SJ.Collins I,C. Ductal earcinomain silu with basal- like phenotype: a possible precursor to invasive basal-like breasl cancer LII. Mod Patho1,2006,19(5 ) :617-621.

共引文献5

同被引文献326

引证文献5

二级引证文献19

中国药物与临床
2012年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部